Alterations in human circulating and bone marrow mononuclear cell polyamine levels in hematologic malignancies as a consequence of difluoromethylornithine administration. [electronic resource]
- Investigational new drugs Jun 1988
- 125-34 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0167-6997
10.1007/BF00195371 doi
Adolescent Adult Aged Biogenic Polyamines--blood Bone Marrow--analysis Eflornithine--pharmacology Female Humans Leukemia--blood Leukocytes, Mononuclear--analysis Male Middle Aged Multiple Myeloma--blood